{
    "code": "02022859",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022859",
    "time": "2021-11-19 03:23:03",
    "許可證字號": "衛署藥輸字第022859號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/04\/25",
    "發證\/登錄日期": "89\/04\/25",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202285902",
    "中文品名": "憶思能膠囊6毫克",
    "英文品名": "EXELON CAPSULES 6MG",
    "適應症": "輕度至中度阿滋海默氏病之失智症。與帕金森氏症相關的輕度至中度失智症。",
    "劑型": "130膠囊劑",
    "包裝": "玻璃容器裝 鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "RIVASTIGMINE HYDROGEN TARTRATE",
    "限制項目": "02輸　入 53依本署七七公告事項八得免除國內進行臨床試驗之特殊醫療需要之新藥",
    "申請商名稱": "1422701100  臺灣諾華股份有限公司",
    "申請商地址": "台北市中正區仁愛路二段99號11、12、13樓",
    "主製造廠": [
        {
            "": "SPAIN",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1204001410",
            "成分名稱": "RIVASTIGMINE HYDROGEN TARTRATE",
            "含量描述": "9.6",
            "含量": "9.6000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "濁紅橙\/鮮黃橙",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "長圓柱形",
        "標記一": "EXELON,6mg",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "02022859.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022859&Seq=435&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Exelon Capsules 1.5,3,4.5,6mg _TWI-300321-110-09-03(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022859&Seq=060&Type=9"
        },
        {
            "title": "憶思能膠囊-108-12-20.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022859&Seq=059&Type=9"
        },
        {
            "title": "Exelon capsule 6mg_FOIL-110-09-03(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022859&Seq=006&Type=8"
        },
        {
            "title": "Exelon capsule 6mg_FB-110-09-03(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022859&Seq=005&Type=8"
        },
        {
            "title": "1129132_ST_14_AB_TW_p1_FB_6mg_for upload_-108-04-02(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022859&Seq=004&Type=8"
        }
    ]
}